The future therapy of endometrial cancer: microRNA’s functionality, capability, and putative clinical application

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Archives of Gynecology and Obstetrics

• Publication date

  2016-09-14

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00404-016-4194-7PMID 27637583
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• TP53 Mutational Spectrum in Endometrioid and Serous Endometrial Cancers

  2016cited by this paper
• The expression of MMP-14 and microRNA-410 in FFPE tissues of human endometrial adenocarcinoma.

  2016cited by this paper
• The correlation between microRNA490-3p and TGFα in endometrial carcinoma tumorigenesis and progression

  2016influential reference
• MicroRNA-505 functions as a tumor suppressor in endometrial cancer by targeting TGF-α

  2016cited by this paper
• Identification of microRNA expression profile related to lymph node status in women with early-stage grade 1–2 endometrial cancer

  2016cited by this paper
• Genetic alterations in endometrial cancer by targeted next-generation sequencing.

  2016influential reference
• MicroRNA-126 inhibits the migration and invasion of endometrial cancer cells by targeting insulin receptor substrate 1.

  2016cited by this paper
• Corrigendum to “MicroRNA and cancer – A brief overview” [Adv Biol Regul 57 (2015) 1–9]

  2015cited by this paper
• Recurrent DICER1 hotspot mutations in endometrial tumours and their impact on microRNA biogenesis

  2015cited by this paper
• A radiosensitivity MiRNA signature validated by the TCGA database for head and neck squamous cell carcinomas

  2015cited by this paper
• MicroRNA-372 inhibits endometrial carcinoma development by targeting the expression of the Ras homolog gene family member C (RhoC)

  2015cited by this paper
• c-Met and RON expression levels in endometrial adenocarcinoma tissue and their relationship with prognosis.

  2015cited by this paper
• MicroRNA‐134 suppresses endometrial cancer stem cells by targeting POGLUT1 and Notch pathway proteins

  2015cited by this paper
• MicroRNA-495 downregulates FOXC1 expression to suppress cell growth and migration in endometrial cancer

  2015cited by this paper
• MicroRNA-424 suppresses estradiol-induced cell proliferation via targeting GPER in endometrial cancer cells.

  2015cited by this paper
• MicroRNA heterogeneity in endometrial cancer cell lines revealed by deep sequencing

  2015cited by this paper
• MicroRNA: The Potential Regulator of Endometrial Carcinogenesis.

  2015cited by this paper
• MicroRNA-424 may function as a tumor suppressor in endometrial carcinoma cells by targeting E2F7.

  2015cited by this paper
• MicroRNA and cancer--a brief overview.

  2015cited by this paper
• The tumor-suppressive microRNA-1/133a cluster targets PDE7A and inhibits cancer cell migration and invasion in endometrial cancer.

  2015cited by this paper
• Cancer statistics, 2015

  2015cited by this paper
• PIKing the type and pattern of PI3K pathway mutations in endometrioid endometrial carcinomas.

  2015cited by this paper
• Hsa-microRNA-181a is a regulator of a number of cancer genes and a biomarker for endometrial carcinoma in patients: a bioinformatic and clinical study and the therapeutic implication

  2015cited by this paper
• MicroRNA miR-302 inhibits the tumorigenicity of endometrial cancer cells by suppression of Cyclin D1 and CDK1.

  2014cited by this paper
• The impact of microRNA-mediated PI3K/AKT signaling on epithelial-mesenchymal transition and cancer stemness in endometrial cancer

  2014cited by this paper
• MicroRNA expression in human endometrial adenocarcinoma

  2014cited by this paper
• MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cells

  2014cited by this paper
• Integrated microRNA and mRNA Transcriptome Sequencing Reveals the Potential Roles of miRNAs in Stage I Endometrioid Endometrial Carcinoma

  2014cited by this paper
• MiR-1 targets PIK3CA and inhibits tumorigenic properties of A549 cells.

  2014cited by this paper
• Application of MicroRNA in Diagnosis and Treatment of Ovarian Cancer

  2014cited by this paper
• MicroRNA-543 suppresses endometrial cancer oncogenicity via targeting FAK and TWIST1 expression

  2014influential reference
• MicroRNA‐106b modulates epithelial–mesenchymal transition by targeting TWIST1 in invasive endometrial cancer cell lines

  2014cited by this paper
• microRNA 31 functions as an endometrial cancer oncogene by suppressing Hippo tumor suppressor pathway

  2014cited by this paper
• MicroRNA-375 inhibits colorectal cancer growth by targeting PIK3CA.

  2014cited by this paper
• Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients

  2013cited by this paper
• Adjuvant sequential chemoradiation therapy in high-risk endometrial cancer: results of a prospective, multicenter phase-II study of the NOGGO (North-Eastern German Society of Gynaecological Oncology)

  2013influential reference
• MicroRNA-182 Promotes Tumor Cell Growth by Targeting Transcription Elongation Factor A-like 7 in Endometrial Carcinoma

  2013cited by this paper
• Integrated genomic characterization of endometrial carcinoma

  2013cited by this paper
• Identification of four serum microRNAs from a genome-wide serum microRNA expression profile as potential non-invasive biomarkers for endometrioid endometrial cancer

  2013cited by this paper
• Aberrant MicroRNA Expression in Endometrial Carcinoma Using Formalin-Fixed Paraffin-Embedded (FFPE) Tissues

  2013cited by this paper
• Bortezomib induces apoptosis of endometrial cancer cells through microRNA‐17‐5p by targeting p21

  2013cited by this paper
• MicroRNA-199a-3p Regulates Endometrial Cancer Cell Proliferation by Targeting Mammalian Target of Rapamycin (mTOR)

  2013cited by this paper
• miR-130b is an EMT-related microRNA that targets DICER1 for aggression in endometrial cancer

  2013cited by this paper
• ZEB1 overexpression associated with E-cadherin and microRNA-200 downregulation is characteristic of undifferentiated endometrial carcinoma

  2013cited by this paper
• Replacement treatment with microRNA-143 and -145 induces synergistic inhibition of the growth of human bladder cancer cells by regulating PI3K/Akt and MAPK signaling pathways.

  2013cited by this paper
• MicroRNA-200b Is Overexpressed in Endometrial Adenocarcinomas and Enhances MMP2 Activity by Downregulating TIMP2 in Human Endometrial Cancer Cell Line HEC-1A Cells

  2013cited by this paper
• MicroRNA-125b down-regulation mediates endometrial cancer invasion by targeting ERBB2

  2012cited by this paper
• Dysregulation of microRNA‐204 mediates migration and invasion of endometrial cancer by regulating FOXC1

  2012cited by this paper
• Review of miR-200b and cancer chemosensitivity.

  2012cited by this paper
• Endometrial Cancer and Hypermethylation: Regulation of DNA and MicroRNA by Epigenetics

  2012cited by this paper
• microRNA-103 regulates the growth and invasion of endometrial cancer cells through the downregulation of tissue inhibitor of metalloproteinase 3.

  2012cited by this paper
• microRNA-21 overexpression contributes to cell proliferation by targeting PTEN in endometrioid endometrial cancer.

  2012cited by this paper
• The interactions between MicroRNA-200c and BRD7 in endometrial carcinoma.

  2012cited by this paper
• MicroRNA‐34b functions as a potential tumor suppressor in endometrial serous adenocarcinoma

  2012cited by this paper
• Mutant p53 gain-of-function induces epithelial–mesenchymal transition through modulation of the miR-130b–ZEB1 axis

  2012cited by this paper
• The genomics and genetics of endometrial cancer.

  2012cited by this paper
• The MicroRNA-200 Family Is Upregulated in Endometrial Carcinoma

  2011cited by this paper
• microRNA-30c negatively regulates endometrial cancer cells by targeting metastasis-associated gene-1.

  2011cited by this paper
• MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1

  2011cited by this paper
• miR-152 is a tumor suppressor microRNA that is silenced by DNA hypermethylation in endometrial cancer.

  2011cited by this paper
• Up‐regulation of microRNA‐145 promotes differentiation by repressing OCT4 in human endometrial adenocarcinoma cells

  2011cited by this paper
• microRNA expression profiling of endometrial endometrioid adenocarcinomas and serous adenocarcinomas reveals profiles containing shared, unique and differentiating groups of microRNAs.

  2011cited by this paper
• Changes in microRNA expression levels correlate with clinicopathological features and prognoses in endometrial serous adenocarcinomas

  2010cited by this paper
• MicroRNA and endometrial cancer: Roles of small RNAs in human tumors and clinical applications (Review).

  2010cited by this paper
• miRNA control of tumor cell invasion and metastasis

  2010cited by this paper
• Comprehensive miRNA profiling of surgically staged endometrial cancer.

  2010cited by this paper
• Factors associated with Type I and Type II endometrial cancer

  2010cited by this paper
• microRNA regulation of the expression of the estrogen receptor in endometrial cancer.

  2010cited by this paper
• MicroRNA signatures differentiate uterine cancer tumor subtypes.

  2010cited by this paper
• Epigenetic repression of microRNA-129-2 leads to overexpression of SOX4 oncogene in endometrial cancer.

  2009cited by this paper
• Dysregulated microRNAs and their predicted targets associated with endometrioid endometrial adenocarcinoma in Hong Kong women

  2009cited by this paper
• Expression profile of mammalian microRNAs in endometrioid adenocarcinoma

  2009cited by this paper
• miR-200 Expression Regulates Epithelial-to-Mesenchymal Transition in Bladder Cancer Cells and Reverses Resistance to Epidermal Growth Factor Receptor Therapy

  2009cited by this paper
• MicroRNA signature and regulatory functions in the endometrium during normal and disease states.

  2008cited by this paper
• MicroRNAs and their target messenger RNAs associated with endometrial carcinogenesis.

  2008cited by this paper
• New aspects of adjuvant therapy in endometrial cancer: current standards and future directions.

  2008cited by this paper
• The noncoding RNA, miR‐126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3‐kinase signaling and is frequently lost in colon cancers

  2008cited by this paper
• microRNAs as oncogenes and tumor suppressors.

  2007cited by this paper
• The expression profile of micro-RNA in endometrium and endometriosis and the influence of ovarian steroids on their expression.

  2007cited by this paper
• miRNAs and apoptosis: RNAs to die for

  2006cited by this paper
• MicroRNAs in cell proliferation, cell death, and tumorigenesis

  2006cited by this paper
• MicroRNAs as oncogenes and tumor suppressors.

  2005cited by this paper
• Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium.

  2004cited by this paper
• Stage II endometrial carcinoma: prognostic factors and risk classification in 170 patients.

  2002cited by this paper
• Epidemiology of endometrial cancer.

  2001cited by this paper
• Physiological roles of matrix metalloproteinases: implications for tumor growth and metastasis.

  1999cited by this paper
• Endometrial carcinoma.

  1996cited by this paper
• Relationship between surgical‐pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A Gynecologic Oncology Group study

  1991cited by this paper
• Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A gynecologic oncology group study

  1991cited by this paper
• Two pathogenetic types of endometrial carcinoma.

  1983cited by this paper
• ENDOMETRIAL CARCINOMA.

  1963cited by this paper

• Determination of endometrial cancer molecular subtypes using a whole exome-sequencing based single-method approach

  2024cites this paper
• Determination of the Cancer Genome Atlas (TCGA) Endometrial Cancer Molecular Subtypes Using the Variant Interpretation and Clinical Decision Support Software MH Guide

  2023cites this paper
• MicroRNA-641 Inhibits Endometrial Cancer Progression via Targeting AP1G1

  2022cites this paper
• miR-20a-5p inhibits endometrial cancer progression by targeting janus kinase 1

  2021cites this paper
• Extracellular vesicle encapsulated microRNA-320a inhibits endometrial cancer by suppression of the HIF1α/VEGFA axis.

  2020cites this paper
• LncRNA TTN-AS1 promotes endometrial cancer by sponging miR-376a-3p

  2020cites this paper
• Estrogen receptor alpha activates MAPK signaling pathway to promote the development of endometrial cancer

  2019cites this paper
• MicroRNA-320a acts as a tumor suppressor in endometrial carcinoma by targeting IGF-1R.

  2019cites this paper
• MicroRNA-20a-5p inhibits epithelial to mesenchymal transition and invasion of endometrial cancer cells by targeting STAT3.

  2018cites this paper
• miR-27a-3p promotes the malignant phenotypes of osteosarcoma by targeting ten-eleven translocation 1.

  2018cites this paper
• Identification of micro-RNA expression profile related to recurrence in women with ESMO low-risk endometrial cancer

  2018cites this paper
• Current Opinion in Gynecology and Obstetrics Evidence for Predictive Markers of Platinum Effectiveness in Ovarian Carcinoma by Microarray-based Comparative Genomic Hybridization

  2018cites this paper
• Epigenetics in endometrial carcinogenesis - part 2: histone modifications, chromatin remodeling and noncoding RNAs.

  2017cites this paper
• MicroRNA: Neglected Biomarkers

  2017cites this paper